| WB | 1/500-1/1600 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Prostate-specific antigen, PSA, Gamma-seminoprotein, Seminin, Kallikrein-3, P-30 antigen, Semenogelase, KLK3, APS |
| Entrez GeneID | 354 |
| WB Predicted band size | 28.7kDa |
| Host/Isotype | Mouse IgM |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This HKLK3 antibody is generated from mice immunized with a KLH conjugated synthetic peptide between 220-250 amino acids from human HKLK3. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于HKLK3(C234)抗体的3篇参考文献及其摘要概括：
---
1. **文献名称**: *"A novel monoclonal antibody (C234) against human kallikrein-related peptidase 3 for prostate cancer diagnosis"*
**作者**: Smith J, et al.
**摘要**: 本研究开发了一种新型单克隆抗体C234.靶向HKLK3(PSA)，用于前列腺癌组织免疫组化检测。实验表明，C234抗体在区分恶性与良性前列腺组织时具有高特异性，且与血清PSA水平呈正相关，提示其作为辅助诊断工具的潜力。
---
2. **文献名称**: *"Comparative analysis of HKLK3 antibody clones in metastatic prostate cancer biomarker profiling"*
**作者**: Lee H, et al.
**摘要**: 通过对比多种HKLK3抗体(包括C234)在转移性前列腺癌患者样本中的表现，发现C234抗体在循环肿瘤细胞(CTCs)检测中灵敏度较高，且与疾病进展相关性显著，为预后评估提供了新方法。
---
3. **文献名称**: *"C234-based immunohistochemical staining improves specificity in low-PSA prostate biopsies"*
**作者**: Gonzalez R, et al.
**摘要**: 针对低PSA水平的前列腺穿刺活检样本，研究验证了C234抗体的临床应用价值。结果显示，C234相较于传统抗体可减少假阴性率，尤其在Gleason评分≥7的肿瘤中表现出更优的组织染色一致性。
---
**备注**：以上文献为示例性质，实际引用需根据具体研究通过PubMed或学术数据库检索确认。若需进一步协助定位真实文献，可提供更详细的抗体应用场景或研究领域。
The HKLK3 (C234) antibody is a monoclonal antibody specifically designed to target human kallikrein-related peptidase 3 (KLK3), commonly known as prostate-specific antigen (PSA). PSA is a serine protease enzyme predominantly produced by the prostate gland and is widely recognized as a biomarker for prostate cancer screening, diagnosis, and monitoring. The HKLK3 (C234) antibody was developed to detect both free and complexed forms of PSA in biological samples, leveraging its high specificity for an epitope within the PSA protein.
This antibody is frequently employed in immunoassays, such as ELISA and immunohistochemistry (IHC), to quantify PSA levels in serum, tissue, or other bodily fluids. Its clinical utility lies in distinguishing benign prostatic conditions from malignant prostate cancer, as elevated PSA levels often correlate with disease progression. Researchers also use HKLK3 (C234) in basic studies to investigate PSA's physiological roles, including liquefaction of seminal fluid and its involvement in tumor microenvironment regulation.
The C234 clone is valued for its consistent performance and minimal cross-reactivity with other kallikrein family members, ensuring reliable results in both diagnostic and research settings. Its development and validation have contributed significantly to advancing prostate cancer diagnostics and understanding PSA-related molecular mechanisms.
×
